| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Infection and Immunity, June 2008, p. 2603-2611, Vol. 76, No. 6
0019-9567/08/$08.00+0 doi:10.1128/IAI.01718-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115
Received 21 December 2007/ Returned for modification 21 February 2008/ Accepted 10 March 2008
The lethal toxin produced by Bacillus anthracis is a bipartite toxin in which the first protein, protective antigen (PA), transports the second protein, lethal factor, across the host cell membrane. We have previously shown that CD8+ T-cell epitopes fused to a nontoxic derivative of lethal factor (LFn) are delivered into the host cell cytosol in a PA-dependent manner. Delivery of these antigens targets them to the intracellular major histocompatibility complex (MHC) class I processing and presentation pathway and leads to the stimulation of antigen-specific CD8+ T cells in vivo. In this report, we describe the generation and characterization of LFn fusion proteins that include not only a CD8+ T-cell epitope but also a CD4+ T-cell epitope. We first show that these fusion proteins induce antigen-specific CD4+ T-cell responses following incubation with dendritic cells in vitro or injection into mice. Stimulation of CD4+ T cells by LFn fusion proteins does not require PA but is enhanced by PA in vitro. We also show that a single LFn fusion protein and PA can deliver antigen to both the MHC class II and the MHC class I pathways, resulting in the simultaneous induction of antigen-specific CD4+ T cells and antigen-specific CD8+ T cells in the same mouse. These results suggest that this toxin delivery system is capable of stimulating protective immune responses where effective immunization requires stimulation of both classes of T cells.
Published ahead of print on 17 March 2008.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|